PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Enlightening cancer cells

Enlightening cancer cells
2014-07-01
(Press-News.org) This news release is available in German.

Harald Janovjak, Assistant Professor at IST Austria, together with Michael Grusch, Associate Professor at the Institute of Cancer Research of the Medical University of Vienna, "remote-controlled" the behaviour of cancer cells with light, as reported this week in EMBO Journal (DOI: 10.15252/embj.201387695). This work is the first application of the new field of optogenetics to cancer research.

To understand the dynamics of cellular signaling, researchers need to activate and inactivate membrane receptor proteins, which serve as relays between a cell's outside and inside world. Ideally, this activation occurs on short timescales (seconds to minutes) and in targeted locations (micrometers to millimeters). However, such a high level of precision in activation cannot be achieved with current pharmacological and genetic methods. Optogenetics uses light to control cell activity, and has the advantage that light can be applied and removed precisely both in space and time. Janovjak, Grusch and colleagues re-engineered receptor tyrosine kinases (RTKs), essential cell surface receptors that sense growth factors and hormones, to be under the control of light.

When a signaling molecule binds to RTKs at the cell surface, two receptors bind to each other in a process called dimerization. This process activates signaling in the cell. Janovjak, Grusch and colleagues linked those parts of mammalian RTKs that activate cell signaling to a light-oxygen-voltage-sensing domain, a reversible light sensor that they identified in a yellow-green alga. In the engineered receptors, the dimerization step and subsequently cell signaling can now be turned on and off by light as the algal proteins sense light and bind to each other. In cancer cells, activation of the engineered receptors causes changes in cell morphology, proliferation and gene expression, characteristic of increased cancer malignancy. In blood cells, activation leads to cell sprouting, typical of the formation of new blood vessels.

The development of RTKs regulated through light-activated dimerization by Janovjak and Grusch is the first instance of light-activated dimerization of mammalian receptors. The engineered receptors can be precisely controlled by a light intensity easily achieved in microscopes and in animal models. The newly developed receptors trigger complex cellular programs in both cancer and blood endothelial cells. These cells represent new models in which behavior is under light control and which can, for instance, be used for new methods to identify drugs. In contrast to cancer, where uncontrolled activation of cell signaling results in features linked to malignancy, light activation of signaling may rescue cell survival and function in degenerative disease. INFORMATION:

[Attachments] See images for this press release:
Enlightening cancer cells Enlightening cancer cells 2

ELSE PRESS RELEASES FROM THIS DATE:

A new method to detect infrared energy using a nanoporous ZnO/n-Si photodetector

A new method to detect infrared energy using a nanoporous ZnO/n-Si photodetector
2014-07-01
Experiments aimed at devising new types of photodetectors have been triggered by the increasing use of optoelectronic devices in personal electronics, cameras, medical equipment, computers and by the military. Professor Zhao Kun and co-researchers at the State Key Laboratory of Petroleum Resource and Prospecting, part of the China University of Petroleum in Beijing, have proposed a new type of infrared photodetector. Photodetectors, which can convert photons to electrical signals, are used to observe and measure the wavelength or energy of light, including infrared light, ...

Drink walkers do it because their mates think it's okay: QUT study

2014-07-01
Friends may be the key to stopping their mates drink walking, a risky behaviour that kills on average two Australians every week, a QUT study has found. Researcher Dr Ioni Lewis, from QUT's Centre for Accident Research & Road Safety - Queensland (CARRS-Q), said in a survey of young people aged 17 to 25, friends were the strongest influence on their intentions to drink walk. "Drink walking, or walking while intoxicated in a public place, is linked to increased risk of injury and fatality," Dr Lewis said. In a survey, published in Transportation Research, more than ...

EORTC presents European solution for effective cancer drug development

2014-07-01
Drug developers are facing the perfect storm. They are confronted with major patent expiries, increased payer scrutiny, changing priorities, shifting business models, increased risk averseness, increased clinical trial costs, not to mention issues concerning R&D productivity. There needs to be a better way to identify new candidate drugs. There needs to be a new drug development pathway that is compatible with research aimed at understanding the biology of a cancer and simultaneously able to support the design and conduct of subsequent confirmatory trials, but building ...

Unsuspected aspect of immune regulation revealed

2014-07-01
A discovery by Australian immunologists, uncovering an additional role for antibody-making 'B cells', is considered important enough by the American Association of Immunologists to rank it among the top 10% of articles in the latest issue of The Journal of Immunology, off the press today. The finding by Senior Research Assistant Stacey Walters and Associate Professor Shane Grey, from Sydney's Garvan Institute of Medical Research, shows that B cells also participate in the development of 'regulatory T cells'. T cells develop in the thymus gland, a soft triangular organ ...

New analysis of 'swine flu' pandemic conflicts with accepted views on how diseases spread

New analysis of swine flu pandemic conflicts with accepted views on how diseases spread
2014-07-01
The most detailed analysis to date of the spread of the H1N1 2009 pandemic influenza virus, known informally as 'swine flu', has found that short-range travel was likely the primary driver for the 2009 pandemic in the United States, in contrast with popularly accepted views on the way diseases spread. The study, based on data gathered from health insurance claims made throughout 2009, found that international air travel, which was previously thought to be important in the pandemic, played only a minor role in its spread within the US. A team of researchers from University ...

Cancer risk: Aspirin and smoking affect aging of genes

Cancer risk: Aspirin and smoking affect aging of genes
2014-07-01
The risk of developing cancer increases with age. Factors like smoking and regular aspirin use also affect the risk of cancer – although in the opposite sense. Researchers from the University of Basel were now able to show that aspirin use and smoking both influence aging processes of the female genome that are connected to colorectal cancer. The Journal of the National Cancer Institute has published their results. Already in the 1990s, scientists discovered that regular use of aspirin over long periods of time decreases the cancer risk. Since then, numerous studies have ...

Analysis of the Chinese facial profile: Contours of the side face in the Tu & Zang ethnic minorities

2014-07-01
Li Haijun and fellow researchers at Minzu University of China, in Beijing, conducted a series of geometric morphometric analyses of the contours of the side face and variations in the Tu and Zang (Tibetan) ethnic minorities from Qinghai Province, in northwestern China. Their study, entitled "Morphometric analysis of the Chinese facial profile: Contours of the side face and variations in the Tu and Zang ethnic minorities", was published (in Chinese) in the Chinese Science Bulletin, 2014, Vol 59(16). The team of researchers used advanced digital cameras and image processing ...

A Spaniard and a Portuguese discover a new species of beetle in the world's deepest cave

A Spaniard and a Portuguese discover a new species of beetle in the worlds deepest cave
2014-07-01
The unusual habitat of the Krubera cave in the Western Caucasus remains a mystery. Researchers from two Spanish universities have discovered a new species of beetle in the depths of this cave. Cave beetles are one of the most iconic species found in subterranean habitats. They were historically the first living organisms described by science that are adapted to the conditions of hypogean or subterranean life. Now, a Portuguese scientist and a Spaniard have discovered a new species of beetle in the deepest cave known to man; a cave 2,140 metres deep. It is the Krubera ...

Scientists uncover the key to adaptation limits of ocean dwellers

2014-07-01
The simpler, the more heat-resistant – scientists uncover the key to adaptation limits of ocean dwellers Bremerhaven, Germany, 1 July 2014. The simpler a marine organism is structured, the better it is suited for survival during climate change. Scientists of the Alfred Wegener Institute, Helmholtz Centre for Polar and Marine Research discovered this in a new meta-study, which appears today in the research journal Global Change Biology. For the first time biologists studied the relationship between the complexity of life forms and the ultimate limits of their adaptation ...

The biology of addiction risk looks like addiction

2014-07-01
Philadelphia, PA, July 1, 2014 – Research suggests that people at increased risk for developing addiction share many of the same neurobiological signatures of people who have already developed addiction. This similarity is to be expected, as individuals with family members who have struggled with addiction are over-represented in the population of addicted people. However, a generation of animal research supports the hypothesis that the addiction process changes the brain in ways that converge with the distinctive neurobiology of the heritable risk for addiction. In other ...

LAST 30 PRESS RELEASES:

BMS-986504 demonstrates durable responses in MTAP-deleted NSCLC, including EGFR and ALK-positive tumors

Phase III trial finds hypofractionated radiotherapy with chemotherapy offers comparable survival and lower toxicity to conventional schedule in LS-SCLC

Lung cancer screening benefits adults up to age 80 if surgical candidates, UK study finds

Video assisted thoracoscopy surgery reduces mortality by 21 percent compared to lobectomy

NADIM ADJUVANT trial suggests benefit of adjuvant chemo-immunotherapy in resected stage IB–IIIA NSCLC

EA5181 phase 3 trial finds no OS benefit for concurrent and consolidative durvalumab vs consolidation alone in unresectable stage 3 NSCLC

Training to improve memory

Are patients undergoing surgery for early-stage cancer at risk of persistent opioid use?

Black youth, especially Black girls, use mental health services less than their White peers

Canada must protect youth from sports betting advertising

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

[Press-News.org] Enlightening cancer cells